RU2021119688A - Pharmaceutical composition of anti-inflammatory action in solid oral dosage form in the form of capsules and method for its production - Google Patents
Pharmaceutical composition of anti-inflammatory action in solid oral dosage form in the form of capsules and method for its production Download PDFInfo
- Publication number
- RU2021119688A RU2021119688A RU2021119688A RU2021119688A RU2021119688A RU 2021119688 A RU2021119688 A RU 2021119688A RU 2021119688 A RU2021119688 A RU 2021119688A RU 2021119688 A RU2021119688 A RU 2021119688A RU 2021119688 A RU2021119688 A RU 2021119688A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- composition according
- starch
- corn starch
- partially pregelatinized
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims 10
- 239000002775 capsule Substances 0.000 title claims 2
- 230000003110 anti-inflammatory Effects 0.000 title 1
- 239000006186 oral dosage form Substances 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
- 229920002261 Corn starch Polymers 0.000 claims 4
- 239000008120 corn starch Substances 0.000 claims 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 4
- 239000000126 substance Substances 0.000 claims 4
- 229920002472 Starch Polymers 0.000 claims 3
- 239000007903 gelatin capsule Substances 0.000 claims 3
- 239000008187 granular material Substances 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 3
- 235000019698 starch Nutrition 0.000 claims 3
- 239000008107 starch Substances 0.000 claims 3
- WSVLPVUVIUVCRA-RJMJUYIDSA-N (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol;hydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-RJMJUYIDSA-N 0.000 claims 2
- ZPDFMQNMOLKHDS-FLIBITNWSA-N (3Z)-3-[2-(4-methylphenyl)-2-oxoethylidene]piperazin-2-one Chemical compound C1=CC(C)=CC=C1C(=O)\C=C/1C(=O)NCCN\1 ZPDFMQNMOLKHDS-FLIBITNWSA-N 0.000 claims 2
- 229910002012 Aerosil® Inorganic materials 0.000 claims 2
- 229960001681 Croscarmellose Sodium Drugs 0.000 claims 2
- 229920002785 Croscarmellose sodium Polymers 0.000 claims 2
- 229960001021 Lactose Monohydrate Drugs 0.000 claims 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinylpyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 2
- 229940075614 colloidal silicon dioxide Drugs 0.000 claims 2
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 claims 2
- 239000007884 disintegrant Substances 0.000 claims 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 2
- 229940021182 non-steroidal anti-inflammatory drugs Drugs 0.000 claims 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims 2
- 229940045902 sodium stearyl fumarate Drugs 0.000 claims 2
- STFSJTPVIIDAQX-LTRPLHCISA-M sodium;(E)-4-octadecoxy-4-oxobut-2-enoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOC(=O)\C=C\C([O-])=O STFSJTPVIIDAQX-LTRPLHCISA-M 0.000 claims 2
- 229960001375 Lactose Drugs 0.000 claims 1
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 claims 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 1
- 229940069328 Povidone Drugs 0.000 claims 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 1
- 239000003831 antifriction material Substances 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 238000007908 dry granulation Methods 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 238000010410 dusting Methods 0.000 claims 1
- 238000005469 granulation Methods 0.000 claims 1
- 230000003179 granulation Effects 0.000 claims 1
- 200000000018 inflammatory disease Diseases 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 1
- 239000008108 microcrystalline cellulose Substances 0.000 claims 1
- 210000002346 musculoskeletal system Anatomy 0.000 claims 1
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 claims 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
Claims (10)
Publications (1)
Publication Number | Publication Date |
---|---|
RU2021119688A true RU2021119688A (en) | 2023-01-09 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK158540B (en) | ORAL, NON-RETARDED DIPYRIDAMOL FORMS AND PROCEDURES FOR THEIR PREPARATION | |
JPH07558B2 (en) | Mopidamole formulation | |
MX2009002371A (en) | Programmable buoyant delivery technology. | |
BRPI0924136B1 (en) | Solid pharmaceutical composition comprising amlodipine and losartan and method for preparing same | |
BR112012028035A2 (en) | dosage form and immediate release formulation, and use of the same | |
CZ293760B6 (en) | Pharmaceutical formulation and process for its preparation | |
RU2153337C2 (en) | Paracetamol and domperidone tablet with film coating | |
BG64348B1 (en) | Paracetamol-containing tablet medicamentous form for swallowing | |
CZ358092A3 (en) | Pharmaceutical preparations with antiphlogistic and analgesic activity | |
JP4567640B2 (en) | Miniaturized sarpogrelate hydrochloride oral dosage form | |
JP4901966B2 (en) | Miniaturized sarpogrelate hydrochloride oral dosage form | |
JP2010120959A5 (en) | ||
RU2108097C1 (en) | Pharmaceutical composition containing ranitidin and bismuth carboxylate salt and method for its preparation | |
EA003878B1 (en) | Process for preparation of swallowable tablets with high n- acetylcysteine content and tablet prepared by the same | |
KR20050053648A (en) | Novel pharmaceutical formulations of modafinil | |
RU2021119688A (en) | Pharmaceutical composition of anti-inflammatory action in solid oral dosage form in the form of capsules and method for its production | |
RU2694056C2 (en) | Anti-tuberculosis stable pharmaceutical composition in form of dispersible tablet containing granulated isoniazid and granulated rifapentine, and method for preparing it | |
JPWO2016088816A1 (en) | Zinc acetate hydrate tablets and process for producing the same | |
WO2019230937A1 (en) | Solid oral dosage form having excellent dissolution properties | |
US20070087051A1 (en) | Pharmaceutical composition | |
TR201605632A1 (en) | SLOW RELEASE COMBINATIONS OF FLURBIPROFEN AND TRAMADOL | |
TW200826962A (en) | Oral solid composition masking bitterness | |
JP2019089758A (en) | Method for improving dissolution in celecoxib-containing tablets | |
JP7004448B2 (en) | Lymaprost-containing lyophilized composition and Limaprost-containing pharmaceutical composition | |
EP2801352B1 (en) | Orally disintegrating formulations of Lacosamid |